Blueprint Medicines Up Over 26%, on Track for Record High Close and Record Percent Increase -- Data Talk

Dow Jones
02 Jun

Blueprint Medicines Corp. $(BPMC)$ is currently at $127.90, up $26.55 or 26.2%

 

--Would be new all-time high (Based on available data back to April 30, 2015)

--Would be largest percent increase on record (Based on available data back to April 30, 2015)

--Currently up two of the past three days

--Up 46.64% year-to-date

--Up 22% from 52 weeks ago (June 3, 2024), when it closed at $104.84

--Would be a new 52-week closing high

--Up 61.45% from its 52-week closing low of $79.22 on April 8, 2025

--Traded as high as $128.15; new all-time intraday high (Based on available data back to April 30, 2015)

--Up 26.44% at today's intraday high; largest intraday percent increase since Oct. 26, 2023, when it rose as much as 30.44%

 

All data as of 11:07:15 AM ET

 

Source: Dow Jones Market Data, FactSet

 

(END) Dow Jones Newswires

June 02, 2025 11:11 ET (15:11 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10